Table 4.
Outcome measure | Outcome category | Reason for high RoB | ||
Bray et al [24]; Taylor et al [56] | Not applicable (no high RoB) | |||
|
Near-vision visual function | Efficacy |
|
|
|
Vision-related QoLa | QoL |
|
|
|
Frequency of use | Usability |
|
|
|
Cost-effectiveness (near-vision visual function vs carer and intervention costs) | Economic |
|
|
Hägglund et al [54] | No blinding; all dropouts in IGb | |||
|
Heart failure self-care behavior | Efficacy |
|
|
|
Health-related QoL | QoLb |
|
|
Hearing aid performance/benefit (Humes et al [49]) |
Efficacy | Per-protocol analysis; recruitment through newspaper ads | ||
Usage frequency (Levine et al [48]) | Usability | No blinding; risk of recruitment bias (people who refused to participate were older, had lower glycated hemoglobin levels, and were less likely to be African American) | ||
Mira et al [50] | Not applicable (no high RoB) | |||
|
Medication adherence | Efficacy |
|
|
|
Medication errors | Efficacy |
|
|
Total length of stay for admitted patients (Ong et al [51]) | Efficacy | No blinding (allocation was discussed with the participants); very high dropout rates in IG (32% vs 1% in the CGc), resulting in a change in the IG:CG ratio from 1:1 to 1:3 | ||
Decrease of diastolic blood pressure (Or and Tao [13]) | Efficacy | No blinding | ||
Fall incidence (Tchalla et al [7]) | Efficacy | No blinding |
aQoL: quality of life.
bIG: intervention group.
cCG: Control group.